131 related articles for article (PubMed ID: 31620216)
1. PROTAC-Mediated Degradation of Estrogen Receptor in the Treatment of Cancer.
Kargbo RB
ACS Med Chem Lett; 2019 Oct; 10(10):1367-1369. PubMed ID: 31620216
[No Abstract] [Full Text] [Related]
2. Exploring the PROTAC degron candidates: OBHSA with different side chains as novel selective estrogen receptor degraders (SERDs).
Li Y; Zhang S; Zhang J; Hu Z; Xiao Y; Huang J; Dong C; Huang S; Zhou HB
Eur J Med Chem; 2019 Jun; 172():48-61. PubMed ID: 30939353
[TBL] [Abstract][Full Text] [Related]
3. New Class of Selective Estrogen Receptor Degraders (SERDs): Expanding the Toolbox of PROTAC Degrons.
Wang L; Guillen VS; Sharma N; Flessa K; Min J; Carlson KE; Toy W; Braqi S; Katzenellenbogen BS; Katzenellenbogen JA; Chandarlapaty S; Sharma A
ACS Med Chem Lett; 2018 Aug; 9(8):803-808. PubMed ID: 30128071
[TBL] [Abstract][Full Text] [Related]
4. Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL.
Lai AC; Toure M; Hellerschmied D; Salami J; Jaime-Figueroa S; Ko E; Hines J; Crews CM
Angew Chem Int Ed Engl; 2016 Jan; 55(2):807-10. PubMed ID: 26593377
[TBL] [Abstract][Full Text] [Related]
5. Degradation of proteins by PROTACs and other strategies.
Wang Y; Jiang X; Feng F; Liu W; Sun H
Acta Pharm Sin B; 2020 Feb; 10(2):207-238. PubMed ID: 32082969
[TBL] [Abstract][Full Text] [Related]
6. Monitoring and deciphering protein degradation pathways inside cells.
Daniels DL; Riching KM; Urh M
Drug Discov Today Technol; 2019 Apr; 31():61-68. PubMed ID: 31200861
[TBL] [Abstract][Full Text] [Related]
7. Bivalent Ligands for Protein Degradation in Drug Discovery.
Scheepstra M; Hekking KFW; van Hijfte L; Folmer RHA
Comput Struct Biotechnol J; 2019; 17():160-176. PubMed ID: 30788082
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Live-Cell Kinetic Degradation and Mechanistic Profiling of PROTAC Mode of Action.
Riching KM; Mahan S; Corona CR; McDougall M; Vasta JD; Robers MB; Urh M; Daniels DL
ACS Chem Biol; 2018 Sep; 13(9):2758-2770. PubMed ID: 30137962
[TBL] [Abstract][Full Text] [Related]
9. [Targeted degradation of epidermal growth factor receptor in nasopharyngeal carcinoma by chimeric molecule].
Dong J; Li S; Wang Q; Xiao W; Yin SC
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(4):297-300. PubMed ID: 29871246
[No Abstract] [Full Text] [Related]
10. Specific MHC-I Peptides Are Induced Using PROTACs.
Jensen SM; Potts GK; Ready DB; Patterson MJ
Front Immunol; 2018; 9():2697. PubMed ID: 30524438
[TBL] [Abstract][Full Text] [Related]
11. In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application.
Drummond ML; Williams CI
J Chem Inf Model; 2019 Apr; 59(4):1634-1644. PubMed ID: 30714732
[TBL] [Abstract][Full Text] [Related]
12. Development of Stabilized Peptide-Based PROTACs against Estrogen Receptor α.
Jiang Y; Deng Q; Zhao H; Xie M; Chen L; Yin F; Qin X; Zheng W; Zhao Y; Li Z
ACS Chem Biol; 2018 Mar; 13(3):628-635. PubMed ID: 29271628
[TBL] [Abstract][Full Text] [Related]
13. Targeting Nuclear Receptors with PROTAC degraders.
Flanagan JJ; Neklesa TK
Mol Cell Endocrinol; 2019 Aug; 493():110452. PubMed ID: 31125586
[TBL] [Abstract][Full Text] [Related]
14. Chimeric molecules to target proteins for ubiquitination and degradation.
Sakamoto KM
Methods Enzymol; 2005; 399():833-47. PubMed ID: 16338398
[TBL] [Abstract][Full Text] [Related]
15. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead.
Bondeson DP; Smith BE; Burslem GM; Buhimschi AD; Hines J; Jaime-Figueroa S; Wang J; Hamman BD; Ishchenko A; Crews CM
Cell Chem Biol; 2018 Jan; 25(1):78-87.e5. PubMed ID: 29129718
[TBL] [Abstract][Full Text] [Related]
16. Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC).
Robb CM; Contreras JI; Kour S; Taylor MA; Abid M; Sonawane YA; Zahid M; Murry DJ; Natarajan A; Rana S
Chem Commun (Camb); 2017 Jul; 53(54):7577-7580. PubMed ID: 28636052
[TBL] [Abstract][Full Text] [Related]
17. Design of a PROTAC that antagonizes and destroys the cancer-forming X-protein of the hepatitis B virus.
Montrose K; Krissansen GW
Biochem Biophys Res Commun; 2014 Oct; 453(4):735-40. PubMed ID: 25305486
[TBL] [Abstract][Full Text] [Related]
18. Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals).
Schiedel M; Herp D; Hammelmann S; Swyter S; Lehotzky A; Robaa D; Oláh J; Ovádi J; Sippl W; Jung M
J Med Chem; 2018 Jan; 61(2):482-491. PubMed ID: 28379698
[TBL] [Abstract][Full Text] [Related]
19. [Targeted degradation of androgen receptors in androgen-independent prostate cancer cells: an experimental study].
Shi YF; Tang YQ; Sun XW; Yu DJ; Han BM; Hong Y; Xia SJ
Zhonghua Nan Ke Xue; 2009 Dec; 15(12):1059-63. PubMed ID: 20180412
[TBL] [Abstract][Full Text] [Related]
20. Identification of New Small-Molecule Inducers of Estrogen-related Receptor α (ERRα) Degradation.
Peng L; Zhang Z; Lei C; Li S; Zhang Z; Ren X; Chang Y; Zhang Y; Xu Y; Ding K
ACS Med Chem Lett; 2019 May; 10(5):767-772. PubMed ID: 31097997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
